|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kumar V, Abbas AK and Aster JC: Robbins
basic pathology. Elsevier Health Sciences; 2012, View Article : Google Scholar
|
|
3
|
Katlic MR, Facktor MA, Berry SA, McKinley
KEA Jr and Steele GD Bothe Jr: ProvenCare lung cancer: A
multi-institutional improvement collaborative. CA Cancer J Clin.
61:382–396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mitsui K, Matsumoto A, Ohtsuka S, Ohtsubo
M and Yoshimura A: Cloning and characterization of a novel
p21(Cip1/Waf1)-interacting zinc finger protein, ciz1. Biochem
Biophys Res Commun. 264:457–464. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Q, Niu N, Wada Y and Liu J: The Role
of Cdkn1A-Interacting Zinc Finger Protein 1 (CIZ1) in DNA
Replication and Pathophysiology. Int J Mol Sci. 17:2122016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coverley D, Marr J and Ainscough J: Ciz1
promotes mammalian DNA replication. J Cell Sci. 118:101–112. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Copeland NA, Sercombe HE, Ainscough JF and
Coverley D: Ciz1 cooperates with cyclin-A-CDK2 to activate
mammalian DNA replication in vitro. J Cell Sci. 123:1108–1115.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Copeland NA, Sercombe HE, Wilson RH and
Coverley D: Cyclin-A-CDK2-mediated phosphorylation of CIZ1 blocks
replisome formation and initiation of mammalian DNA replication. J
Cell Sci. 128:1518–1527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang DQ, Wang K, Yan DW, Liu J, Wang B, Li
MX, Wang XW, Liu J, Peng ZH, Li GX and Yu ZH: Ciz1 is a novel
predictor of survival in human colon cancer. Exp Biol Med
(Maywood). 239:862–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang D, Wang Y, Dai Y, Wang J, Suo T, Pan
H and Liu H, Shen S and Liu H: CIZ1 promoted the growth and
migration of gallbladder cancer cells. Tumour Biol. 36:2583–2591.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu T, Ren X, Li L, Yin L, Liang K, Yu H,
Ren H, Zhou W, Jing H and Kong C: Ciz1 promotes tumorigenicity of
prostate carcinoma cells. Front Biosci (Landmark Ed). 20:705–715.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim NS, Hahn Y, Oh JH, Lee JY, Oh KJ, Kim
JM, Park HS, Kim S, Song KS, Rho SM, et al: Gene cataloging and
expression profiling in human gastric cancer cells by expressed
sequence tags. Genomics. 83:1024–1045. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu X, Chen H, Jin M, Wang X, Lee J, Xu W,
Zhang R, Li S and Niu J: Molecular cytogenetic characterization of
undifferentiated embryonal sarcoma of the liver: A case report and
literature review. Mol Cytogenet. 5:262012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Higgins G, Roper KM, Watson IJ, Blackhall
FH, Rom WN, Pass HI, Ainscough JF and Coverley D: Variant Ciz1 is a
circulating biomarker for early-stage lung cancer. Proc Natl Acad
Sci USA. 109:pp. E3128–E3135. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Komiya T, Hosono Y, Hirashima T, Masuda N,
Yasumitsu T, Nakagawa K, Kikui M, Ohno A, Fukuoka M and Kawase I:
p21 expression as a predictor for favorable prognosis in squamous
cell carcinoma of the lung. Clin Cancer Res. 3:1831–1835.
1997.PubMed/NCBI
|
|
16
|
Caputi M, Esposito V, Baldi A, De Luca A,
Dean C, Signoriello G, Baldi F and Giordano A: p21waf1/cip1mda-6
expression in non-small-cell lung cancer: Relationship to survival.
Am J Respir Cell Mol Biol. 18:213–217. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shoji T, Tanaka F, Takata T, Yanagihara K,
Otake Y, Hanaoka N, Miyahara R, Nakagawa T, Kawano Y, Ishikawa S,
et al: Clinical significance of p21 expression in non-small-cell
lung cancer. J Clin Oncol. 20:3865–3871. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Esposito V, Baldi A, Tonini G, Vincenzi B,
Santini M, Ambrogi V, Mineo TC, Persichetti P, Liuzzi G,
Montesarchio V, et al: Analysis of cell cycle regulator proteins in
non-small cell lung cancer. J Clin Pathol. 57:58–63. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Li Y and Hoh J: Generation and
characterization of mice with a conditional null allele of the
HtrA4 gene. Mol Med Rep. 12:6768–6774. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin J, Wang C, Tang X, Sun H, Shao Q, Yang
X and Qu X: CIZ1 regulates the proliferation, cycle distribution
and colony formation of RKO human colorectal cancer cells. Mol Med
Rep. 8:1630–1634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kawai H, Ishii A, Washiya K, Konno T, Kon
H, Yamaya C, Ono I, Minamiya Y and Ogawa J: Estrogen receptor alpha
and beta are prognostic factors in non-small cell lung cancer. Clin
Cancer Res. 11:5084–5089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schwartz AG, Prysak GM, Murphy V, Lonardo
F, Pass H, Schwartz J and Brooks S: Nuclear estrogen receptor beta
in lung cancer: Expression and survival differences by sex. Clin
Cancer Res. 11:7280–7287. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
den Hollander P, Rayala SK, Coverley D and
Kumar R: Ciz1, a Novel DNA-binding coactivator of the estrogen
receptor alpha, confers hypersensitivity to estrogen action. Cancer
Res. 66:11021–11029. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Uematsu K, He B, You L, Xu Z, McCormick F
and Jablons DM: Activation of the Wnt pathway in non small cell
lung cancer: Evidence of dishevelled overexpression. Oncogene.
22:7218–7221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shojaei F: Anti-angiogenesis therapy in
cancer: Current challenges and future perspectives. Cancer Lett.
320:130–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Owen MR, Alarcón T, Maini PK and Byrne HM:
Angiogenesis and vascular remodelling in normal and cancerous
tissues. J Mathematical Biol. 58:689–721. 2009. View Article : Google Scholar
|
|
28
|
Abbas T and Dutta A: p21 in cancer:
Intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weiss RH: p21Waf1/Cip1 as a therapeutic
target in breast and other cancers. Cancer Cell. 4:425–429. 2003.
View Article : Google Scholar : PubMed/NCBI
|
